Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.
MacIsaac MB, Whitton B, Anderson J, Cogger S, Vella-Horne D, Penn M, Weeks A, Elmore K, Pemberton D, Winter RJ, Papaluca T, Howell J, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Clark N, Holmes JA, Thompson AJ. MacIsaac MB, et al. Among authors: pedrana a. Int J Drug Policy. 2024 Mar;125:104317. doi: 10.1016/j.drugpo.2024.104317. Epub 2024 Jan 28. Int J Drug Policy. 2024. PMID: 38281385
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J, Doyle J, Zordan R, Weiland T, Cocco A, Howell J, Iser S, Snell J, Fry S, New K, Sloane R, Jarman M, Phan D, Tran S, Pedrana A, Williams B, Johnson J, Glasgow S, Thompson A. Hutton J, et al. Among authors: pedrana a. Int J Drug Policy. 2019 Oct;72:84-90. doi: 10.1016/j.drugpo.2019.06.021. Epub 2019 Jul 24. Int J Drug Policy. 2019. PMID: 31351752
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020.
Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A. Wilkinson AL, et al. Among authors: pedrana a. Int J Drug Policy. 2022 May;103:103655. doi: 10.1016/j.drugpo.2022.103655. Epub 2022 Mar 26. Int J Drug Policy. 2022. PMID: 35349964
Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020.
Dawe J, Wilkinson AL, Asselin J, Carter A, Pedrana A, Traeger MW, Thomas AJ, Curtis M, Cooper M, Howell J, Doyle JS, Hellard ME, Stoové M; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood borne viruses and sexually transmissible infections (ACCESS). Dawe J, et al. Among authors: pedrana a. Int J Drug Policy. 2022 Jun;104:103696. doi: 10.1016/j.drugpo.2022.103696. Epub 2022 Apr 28. Int J Drug Policy. 2022. PMID: 35490624
Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
MacIsaac MB, Whitton B, Hubble A, Cogger S, Penn M, Weeks A, Elmore K, Pemberton D, Anderson J, Howard R, McKeever U, Papaluca T, Hellard ME, Stoove M, Wilson D, Pedrana A, Doyle J, Clark N, Holmes J, Thompson AJ. MacIsaac MB, et al. Among authors: pedrana a. Med J Aust. 2023 Apr 3;218(6):256-261. doi: 10.5694/mja2.51885. Epub 2023 Mar 14. Med J Aust. 2023. PMID: 36919230
127 results